CHEK1 and ovarian cancer: To this end, we performed a genome-wide CRISPR knockout screen in an ovarian cancer derived cell line (OVCAR8) and quantified the effect of individual gene knockouts on the cell viability following treatment with a CHK1/2 checkpoint kinase inhibitor, Prexasertib, for 10 generations (see Methods).